Bioactive Compounds Targeting Dihydroceramide and Their Therapeutic Potential in Cancer Treatment

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2025 Mar 13

PMID 40075756

Authors

Yumi Jang

Affiliations

Soon will be listed here.

Abstract

Dihydroceramide (dhCer) was previously considered an inactive precursor of ceramide, a well-known sphingoid base involved in regulating apoptosis and cell death. However, recent studies have shown that dhCer plays a crucial role in various important cellular responses. In this review, we summarize the latest findings on the biological functions of dhCer and the enzymes involved in its biosynthesis. We specifically focus on the emerging evidence implicating dhCer in cancer, as well as its role in regulating key processes such as cell cycle arrest, autophagy, apoptosis, ER stress, and oxidative stress. Furthermore, we discuss bioactive compounds that can modulate dhCer levels in cancer cells, highlighting their potential therapeutic applications in counteracting cancer progression. This review emphasizes the growing recognition of dhCer as a bioactive sphingolipid metabolite with significant potential for cancer therapy.

References

Triola G, Fabrias G, Dragusin M, Niederhausen L, Broere R, Llebaria A . Specificity of the dihydroceramide desaturase inhibitor N-[(1R,2S)-2-hydroxy-1-hydroxymethyl-2-(2-tridecyl-1-cyclopropenyl)ethyl]octanamide (GT11) in primary cultured cerebellar neurons. Mol Pharmacol. 2004; 66(6):1671-8. DOI: 10.1124/mol.104.003681. View

Janneh A, Ogretmen B . Targeting Sphingolipid Metabolism as a Therapeutic Strategy in Cancer Treatment. Cancers (Basel). 2022; 14(9). PMC: 9104917. DOI: 10.3390/cancers14092183. View

Tzou F, Su T, Lin W, Kuo H, Yu Y, Yeh Y . Dihydroceramide desaturase regulates the compartmentalization of Rac1 for neuronal oxidative stress. Cell Rep. 2021; 35(2):108972. DOI: 10.1016/j.celrep.2021.108972. View

Stiban J, Fistere D, Colombini M . Dihydroceramide hinders ceramide channel formation: Implications on apoptosis. Apoptosis. 2006; 11(5):773-80. DOI: 10.1007/s10495-006-5882-8. View

Hannun Y, Obeid L . Many ceramides. J Biol Chem. 2011; 286(32):27855-62. PMC: 3151029. DOI: 10.1074/jbc.R111.254359. View

Rahmaniyan M, Curley Jr R, Obeid L, Hannun Y, Kraveka J . Identification of dihydroceramide desaturase as a direct in vitro target for fenretinide. J Biol Chem. 2011; 286(28):24754-64. PMC: 3137051. DOI: 10.1074/jbc.M111.250779. View

Wang H, Maurer B, Liu Y, Wang E, Allegood J, Kelly S . N-(4-Hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing. Mol Cancer Ther. 2008; 7(9):2967-76. DOI: 10.1158/1535-7163.MCT-08-0549. View

Jang Y, Kim C . The Role of Vitamin E Isoforms and Metabolites in Cancer Prevention: Mechanistic Insights into Sphingolipid Metabolism Modulation. Nutrients. 2024; 16(23). PMC: 11644559. DOI: 10.3390/nu16234115. View

Fabrias G, Munoz-Olaya J, Cingolani F, Signorelli P, Casas J, Gagliostro V . Dihydroceramide desaturase and dihydrosphingolipids: debutant players in the sphingolipid arena. Prog Lipid Res. 2011; 51(2):82-94. DOI: 10.1016/j.plipres.2011.12.002. View

10.

Ternes P, Franke S, Zahringer U, Sperling P, Heinz E . Identification and characterization of a sphingolipid delta 4-desaturase family. J Biol Chem. 2002; 277(28):25512-8. DOI: 10.1074/jbc.M202947200. View

11.

Idkowiak-Baldys J, Apraiz A, Li L, Rahmaniyan M, Clarke C, Kraveka J . Dihydroceramide desaturase activity is modulated by oxidative stress. Biochem J. 2010; 427(2):265-74. PMC: 3086801. DOI: 10.1042/BJ20091589. View

12.

Gopalan A, Yu W, Jiang Q, Jang Y, Sanders B, Kline K . Involvement of de novo ceramide synthesis in gamma-tocopherol and gamma-tocotrienol-induced apoptosis in human breast cancer cells. Mol Nutr Food Res. 2012; 56(12):1803-11. DOI: 10.1002/mnfr.201200350. View

13.

Jiang Q, Wong J, Fyrst H, Saba J, Ames B . gamma-Tocopherol or combinations of vitamin E forms induce cell death in human prostate cancer cells by interrupting sphingolipid synthesis. Proc Natl Acad Sci U S A. 2004; 101(51):17825-30. PMC: 535585. DOI: 10.1073/pnas.0408340102. View

14.

Siddique M, Li Y, Chaurasia B, Kaddai V, Summers S . Dihydroceramides: From Bit Players to Lead Actors. J Biol Chem. 2015; 290(25):15371-15379. PMC: 4505450. DOI: 10.1074/jbc.R115.653204. View

15.

Schiffmann S, Sandner J, Schmidt R, Birod K, Wobst I, Schmidt H . The selective COX-2 inhibitor celecoxib modulates sphingolipid synthesis. J Lipid Res. 2008; 50(1):32-40. DOI: 10.1194/jlr.M800122-JLR200. View

16.

Jang Y, Park N, Rostgaard-Hansen A, Huang J, Jiang Q . Vitamin E metabolite 13'-carboxychromanols inhibit pro-inflammatory enzymes, induce apoptosis and autophagy in human cancer cells by modulating sphingolipids and suppress colon tumor development in mice. Free Radic Biol Med. 2016; 95:190-9. PMC: 4867259. DOI: 10.1016/j.freeradbiomed.2016.03.018. View

17.

Hernandez-Tiedra S, Fabrias G, Davila D, Salanueva I, Casas J, Montes L . Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization. Autophagy. 2016; 12(11):2213-2229. PMC: 5103338. DOI: 10.1080/15548627.2016.1213927. View

18.

Boppana N, Delor J, Van Buren E, Bielawska A, Bielawski J, Pierce J . Enhanced apoptotic cancer cell killing after Foscan photodynamic therapy combined with fenretinide via de novo sphingolipid biosynthesis pathway. J Photochem Photobiol B. 2016; 159:191-5. PMC: 6123833. DOI: 10.1016/j.jphotobiol.2016.02.040. View

19.

Signorelli P, Munoz-Olaya J, Gagliostro V, Casas J, Ghidoni R, Fabrias G . Dihydroceramide intracellular increase in response to resveratrol treatment mediates autophagy in gastric cancer cells. Cancer Lett. 2009; 282(2):238-43. DOI: 10.1016/j.canlet.2009.03.020. View

20.

Triola G, Fabrias G, Casas J, Llebaria A . Synthesis of cyclopropene analogues of ceramide and their effect on dihydroceramide desaturase. J Org Chem. 2003; 68(26):9924-32. DOI: 10.1021/jo030141u. View